Skip to main content
Premium Trial:

Request an Annual Quote

Three Max Planck Institutes to Demo Rosetta Resolver Software and New Agilent Scanner

NEW YORK, Aug. 7 - Rosetta Inpharmatics and Agilent Technologies said Tuesday that the Max Planck Institutes for Molecular Genetics, Infection Biology, and Molecular Plant Physiology would act as European demonstration sites for the Rosetta Resolver Gene Expression Data Analysis System and Agilent’s DNA Microarray Scanner. 

Rosetta Inpharmatics, based in Kirkland, Wash., also said it has launched a satellite customer service operation in Europe, housed at Agilent Technologies' facility in Amsterdam, The Netherlands. 

Bill Buffington, vice president and general manager of Agilent Technologies' life sciences division, said the deal with the German research institutes would “allow greater access to the Rosetta Resolver system and Agilent's new open-systems-based DNA Microarray Scanner for prospective users in Europe.”

Financial details of the agreement were not disclosed.

Agilent, based in Palo Alto, Calif., said its new DNA Microarray Scanner scans industry-standard 1-inch by 3-inch glass slides and offers automated 48-slide scanning. Agilent holds exclusive distribution rights to the Rosetta Resolver enterprise bioinformatics system for gene expression data analysis. 

In May, Merck acquired Rosetta for $620 million in stock, but said that Rosetta would continue to operate the Resolver business as a separate cost center and that the acquisition would not affect the alliance between Rosetta and Agilent.   
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.